Safety, Tolerability and Acceptability of Long-Acting Cabotegravir (CAB LA) for the Prevention of HIV Among Adolescent Males
Clinical trial NCT04692077 · COMPLETED
Trial details
- NCT number
- NCT04692077
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-19
- Primary completion
- 2023-07-07
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.